🧠 AI clinical summary is being generated for this article and will appear shortly.
Source
NICE
Published
25 Mar 2026
Last Indexed
25 Mar 2026
Specialty
Respiratory / COPD / Asthma

NICE NG80 provides guidance on the diagnosis and management of asthma in adults and children, including updated stepwise treatment ladder and monitoring approaches.

Key Recommendations

  • Diagnosis: objective evidence of reversible airflow obstruction or bronchial hyperresponsiveness
  • Step 1: As-needed SABA reliever inhaler
  • Step 2: Add low-dose ICS (preventer). First-line: beclomethasone 200mcg/day or equivalent
  • Step 3: Add LABA to ICS (combination inhaler). If inadequate: increase ICS dose
  • Step 4: Refer to specialist. Consider LTRA, theophylline, or biologic therapy
  • Biologics (dupilumab, mepolizumab, benralizumab) for severe eosinophilic asthma
  • Annual asthma review for all patients: adherence, inhaler technique, written action plan
ClinicalIQ Editorial Note: This guideline summary is indexed from NICE. Always refer to the full guideline for complete recommendations. Last indexed: 25 Mar 2026
Share: 𝕏 Twitter/X 🔗 LinkedIn View on NICE ↗

More in Respiratory / COPD / Asthma